OMER (Omeros Corporation) Stock Analysis - Hedge Fund Holdings
Omeros Corporation (OMER) is a publicly traded Healthcare sector company. As of May 21, 2026, OMER trades at $12.58 with a market cap of $846.79M and a P/E ratio of 9.45. OMER moved +3.43% today. Year to date, OMER is -19.61%; over the trailing twelve months it is +276.29%. Its 52-week range spans $2.95 to $17.65. Analyst consensus is buy with an average price target of $40.00. Rallies surfaces OMER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns OMER stock?
Hedge funds tracked by Rallies that own OMER include Sculptor Capital and Farallon Capital. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Omeros Corporation.
OMER Key Metrics
Key financial metrics for OMER
Metric
Value
Price
$12.58
Market Cap
$846.79M
P/E Ratio
9.45
EPS
$1.30
Dividend Yield
0.00%
52-Week High
$17.65
52-Week Low
$2.95
Volume
586
Avg Volume
0
Revenue (TTM)
$9.89M
Net Income
$86.17M
Gross Margin
0.00%
Top Hedge Funds Holding OMER
Sculptor Capital holds 94.00K shares of OMER, changed -2.08% as of Dec 31, 2024.
Farallon Capital holds 23.00K shares of OMER, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own OMER include Sculptor Capital and Farallon Capital. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Omeros Corporation.
Does Rallies show 13F holders for OMER?
Yes. Rallies tracks hedge fund and 13F ownership data for OMER, including fund names, share counts, latest tracked quarter, and position changes when available.
Is OMER research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OMER. It does not provide personalized investment advice.